Evidence map›Paper›PMID 34395639›Full record

ReviewFuture journal of pharmaceutical sciences2021

A review on corona virus and treatment approaches with

Rupesh Kumar Pandey, Ravindra Kumar Pandey, Shiv Shankar Shukla, Priyanka Pandey

Abstract readReview
In one paragraph

Review in Future journal of pharmaceutical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rupesh Kumar PandeyDepartment of Pharmacology KSCP, Swami Vivekanand Subharti University, Meerut, Uttar Pradesh India.
Ravindra Kumar PandeyColumbia Institutes of Pharmacy, Raipur, Chhattisgarh India.
Shiv Shankar ShuklaColumbia Institutes of Pharmacy, Raipur, Chhattisgarh India.
Priyanka PandeySwami Vivekanand College of Pharmacy, Indore, Madhya Pradesh India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently reported cases of Covid-19 globally remind us that new diseases are coming while we are unable to provide the treatment for the same. The entire world is facing this viral attack; deaths are increasing day by day as well as infected patients too. Today, in the period of this disease, can we go to the shelter of our traditional medicines? MAIN BODY: In this article, we have taken medicines related to corona and conceptualized their mechanism, which gave us a chance to understand Garlic's mechanism of action, how Garlic can be a weapon in the lane with this disease. This article also tells how we can treat new diseases with our traditional herbs if no modern medicine has been discovered yet.

conclusionThe present review is based on the structure of the virus and the targeted site for the drug discovery process with important constituents of

Indexed as

AllicinAngiotensin-converting enzymeAntiviralAyurvedaCytokinesLung edema

Identifiers

PMID34395639
PMCPMC8353433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.